ARTICLES:

D Henrion, JM Chillon, C Capdeville-Atkinson, and J Atkinson

Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats
J Pharmacol Exp Ther 1992 260: 1-8. [Abstract] [PDF]  

L Toll

Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes
J Pharmacol Exp Ther 1992 260: 9-15. [Abstract] [PDF]  

ME Newman, B Shapira, and B Lerer

Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by short- and long-term administration of 5- hydroxytryptamine1A agonist and antidepressants
J Pharmacol Exp Ther 1992 260: 16-20. [Abstract] [PDF]  

SO Casalotti, AP Kozikowski, A Fauq, W Tuckmantel, and KE Krueger

Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors
J Pharmacol Exp Ther 1992 260: 21-28. [Abstract] [PDF]  

U Humke, N Levens, J Wood, and K Hofbauer

The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system
J Pharmacol Exp Ther 1992 260: 29-35. [Abstract] [PDF]  

JW Mandema, E Tukker, and M Danhof

In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil
J Pharmacol Exp Ther 1992 260: 36-44. [Abstract] [PDF]  

RP Waite and CC Pang

The sympathetic nervous system facilitates endothelin-1 effects on venous tone
J Pharmacol Exp Ther 1992 260: 45-50. [Abstract] [PDF]  

MM Foreman, RW Fuller, DL Nelson, DO Calligaro, KD Kurz, JW Misner, WL Garbrecht, and CJ Parli

Preclinical studies on LY237733, a potent and selective serotonergic antagonist
J Pharmacol Exp Ther 1992 260: 51-57. [Abstract] [PDF]  

MV Westfall, GM Wahler, K Fujino, and RJ Solaro

Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium
J Pharmacol Exp Ther 1992 260: 58-63. [Abstract] [PDF]  

CV Jackson, JD Frank, TJ Craft, JL Sundboom, and GF Smith

Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis
J Pharmacol Exp Ther 1992 260: 64-70. [Abstract] [PDF]  

WE Evans, JH Rodman, MV Relling, WP Petros, CF Stewart, CH Pui, and GK Rivera

Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemia
J Pharmacol Exp Ther 1992 260: 71-77. [Abstract] [PDF]  

JH Kehne, TC McCloskey, VL Taylor, CK Black, GM Fadayel, and CJ Schmidt

Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats
J Pharmacol Exp Ther 1992 260: 78-89. [Abstract] [PDF]  

KS Murthy, JR Grider, and GM Makhlouf

Receptor-coupled G proteins mediate contraction and Ca++ mobilization in isolated intestinal muscle cells
J Pharmacol Exp Ther 1992 260: 90-97. [Abstract] [PDF]  

RJ Altiere, L Diamond, and DC Thompson

Omega-conotoxin-sensitive calcium channels modulate autonomic neurotransmission in guinea pig airways
J Pharmacol Exp Ther 1992 260: 98-103. [Abstract] [PDF]  

MA Carroll, MP Garcia, JR Falck, and JC McGiff

Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites
J Pharmacol Exp Ther 1992 260: 104-109. [Abstract] [PDF]  

Y Zhu and WB Im

Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells
J Pharmacol Exp Ther 1992 260: 110-116. [Abstract] [PDF]  

SP Welch, DL Stevens, and WL Dewey

A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse
J Pharmacol Exp Ther 1992 260: 117-127. [Abstract] [PDF]  

DA Griffiths, SD Hall, and PP Sokol

Effect of 3'-azido-3'-deoxythymidine (AZT) on organic ion transport in rat renal brush border membrane vesicles
J Pharmacol Exp Ther 1992 260: 128-133. [Abstract] [PDF]  

SJ Vyas, J Eichberg, and MF Lokhandwala

Characterization of receptors involved in dopamine-induced activation of phospholipase-C in rat renal cortex
J Pharmacol Exp Ther 1992 260: 134-139. [Abstract] [PDF]  

LE Osthaus and JJ Galligan

Antagonists of nitric oxide synthesis inhibit nerve-mediated relaxations of longitudinal muscle in guinea pig ileum
J Pharmacol Exp Ther 1992 260: 140-145. [Abstract] [PDF]  

AA Megens, FH Awouters, TF Meert, KH Schellekens, CJ Niemegeers, and PA Janssen

Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598)
J Pharmacol Exp Ther 1992 260: 146-159. [Abstract] [PDF]  

AA Megens, CJ Niemegeers, and FH Awouters

Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol
J Pharmacol Exp Ther 1992 260: 160-167. [Abstract] [PDF]  

FJ Ayesta, A Ableitner, MW Emmett-Oglesby, A Herz, and TS Shippenberg

Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation
J Pharmacol Exp Ther 1992 260: 168-174. [Abstract] [PDF]  

RM Edwards, N Aiyar, EH Ohlstein, EF Weidley, E Griffin, M Ezekiel, RM Keenan, RR Ruffolo, and J Weinstock

Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566
J Pharmacol Exp Ther 1992 260: 175-181. [Abstract] [PDF]  

SM Crain and KF Shen

After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition
J Pharmacol Exp Ther 1992 260: 182-186. [Abstract] [PDF]  

D Villani-Price, DC Yang, RE Walsh, DJ Fretland, RH Keith, G Kocan, JF Kachur, TS Gaginella, and BS Tsai

Multiple actions of the leukotriene B4 receptor antagonist SC-41930
J Pharmacol Exp Ther 1992 260: 187-191. [Abstract] [PDF]  

DT Taneja and DE Clarke

Evidence for a noradrenergic innervation to "atypical" beta adrenoceptors (or putative beta-3 adrenoceptors) in the ileum of guinea pig
J Pharmacol Exp Ther 1992 260: 192-200. [Abstract] [PDF]  

DR Compton, MR Johnson, LS Melvin, and BR Martin

Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents
J Pharmacol Exp Ther 1992 260: 201-209. [Abstract] [PDF]  

MG Paule, RR Allen, JR Bailey, AC Scallet, SF Ali, RM Brown, and W Jr Slikker

Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding
J Pharmacol Exp Ther 1992 260: 210-222. [Abstract] [PDF]  

EK Jackson

In vivo evaluation of the antagonist activity of angiotensin I analogs
J Pharmacol Exp Ther 1992 260: 223-231. [Abstract] [PDF]  

A Pittaluga and M Raiteri

N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization
J Pharmacol Exp Ther 1992 260: 232-237. [Abstract] [PDF]  

M Raiteri, B Garrone, and A Pittaluga

N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal [published erratum appears in J Pharmacol Exp Ther 1992 Jul;262(1):449]
J Pharmacol Exp Ther 1992 260: 238-242. [Abstract] [PDF]  

C Jarusiripipat, L Chan, JI Shapiro, and RW Schrier

Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats
J Pharmacol Exp Ther 1992 260: 243-247. [Abstract] [PDF]  

CL Cowan and RA Cohen

Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers
J Pharmacol Exp Ther 1992 260: 248-253. [Abstract] [PDF]  

F Ciampolillo, DE Tung, and JS Cameron

Effects of diazoxide and glyburide on ATP-sensitive K+ channels from hypertrophied ventricular myocytes
J Pharmacol Exp Ther 1992 260: 254-260. [Abstract] [PDF]  

CC Shieh, MF Petrini, TM Dwyer, and JM Farley

Cromakalim effects of acetylcholine-induced changes in cytosolic calcium and tension in swine trachealis
J Pharmacol Exp Ther 1992 260: 261-268. [Abstract] [PDF]  

AJ Nichols, PF Koster, DP Brooks, and RR Jr Ruffolo

Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog
J Pharmacol Exp Ther 1992 260: 269-274. [Abstract] [PDF]  

RB Raffa, E Friderichs, W Reimann, RP Shank, EE Codd, and JL Vaught

Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic
J Pharmacol Exp Ther 1992 260: 275-285. [Abstract] [PDF]  

JE Shaffer, BJ Han, WH Chern, and FW Lee

Lack of tolerance to a 24-hour infusion of S-nitroso N- acetylpenicillamine (SNAP) in conscious rabbits
J Pharmacol Exp Ther 1992 260: 286-293. [Abstract] [PDF]  

ND Binder and JJ Faber

Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits
J Pharmacol Exp Ther 1992 260: 294-299. [Abstract] [PDF]  

AM Bendele, DN Benslay, JT Hom, SM Spaethe, KJ Ruterbories, TD Lindstrom, SJ Lee, and RW Naismith

Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis
J Pharmacol Exp Ther 1992 260: 300-305. [Abstract] [PDF]  

JJ Galligan

Differential inhibition of cholinergic and noncholinergic neurogenic contractions by 5-hydroxytryptamine1A receptor agonists in guinea pig ileum
J Pharmacol Exp Ther 1992 260: 306-312. [Abstract] [PDF]  

T Yamada, K Fujimoto, P Tso, T Fujimoto, TS Gaginella, and MB Grisham

Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis
J Pharmacol Exp Ther 1992 260: 313-318. [Abstract] [PDF]  

MK Dong, ME Scott, DJ Schrier, MJ Suto, JC Sircar, A Black, T Chang, and RB Gilbertsen

The biochemistry and pharmacology of PD 116124 (8-amino-2'- nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP)
J Pharmacol Exp Ther 1992 260: 319-326. [Abstract] [PDF]  

RM Craft and LA Dykstra

Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output
J Pharmacol Exp Ther 1992 260: 327-333. [Abstract] [PDF]  

RM Craft and LA Dykstra

Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment
J Pharmacol Exp Ther 1992 260: 334-342. [Abstract] [PDF]  

JS Brog and MC Beinfeld

Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor
J Pharmacol Exp Ther 1992 260: 343-348. [Abstract] [PDF]  

RW Lee, TE Raya, U Michael, S Foster, T Meeks, and S Goldman

Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure
J Pharmacol Exp Ther 1992 260: 349-354. [Abstract] [PDF]  

PD Kanof, L Handelsman, MJ Aronson, R Ness, KJ Cochrane, and KJ Rubinstein

Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects
J Pharmacol Exp Ther 1992 260: 355-363. [Abstract] [PDF]  

A De Luca, D Tricarico, R Wagner, SH Bryant, V Tortorella, and D Conte Camerino

Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions
J Pharmacol Exp Ther 1992 260: 364-368. [Abstract] [PDF]  

OH Choi, WL Padgett, and JW Daly

Effects of the amphiphilic peptides melittin and mastoparan on calcium influx, phosphoinositide breakdown and arachidonic acid release in rat pheochromocytoma PC12 cells
J Pharmacol Exp Ther 1992 260: 369-375. [Abstract] [PDF]  

AW Wamil and MJ McLean

Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture
J Pharmacol Exp Ther 1992 260: 376-383. [Abstract] [PDF]  

JM Bathon, DC Manning, DW Goldman, MC Towns, and D Proud

Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1
J Pharmacol Exp Ther 1992 260: 384-392. [Abstract] [PDF]  

PJ Sausen, AA Elfarra, and AJ Cooley

Methimazole protection of rats against chemically induced kidney damage in vivo
J Pharmacol Exp Ther 1992 260: 393-401. [Abstract] [PDF]  

M Morelli, S Fenu, A Pinna, and G Di Chiara

Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2- mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression
J Pharmacol Exp Ther 1992 260: 402-408. [Abstract] [PDF]  

KX Huang and JR Walters

D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N- methyl-D-aspartate antagonists
J Pharmacol Exp Ther 1992 260: 409-416. [Abstract] [PDF]  

A Remaury and H Paris

The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites
J Pharmacol Exp Ther 1992 260: 417-426. [Abstract] [PDF]  

SM Tejani-Butt

[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding
J Pharmacol Exp Ther 1992 260: 427-436. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.